Factors that influence the recruitment of patients to Phase III studies in oncology

The perspective of the clinical research associate

Authors

  • James R. Wright B.Sc., M.D.,

    Corresponding author
    1. Hamilton Regional Cancer Centre, Cancer Care Ontario, Hamilton, Ontario, Canada
    2. Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Department of Radiation Oncology, Hamilton Regional Cancer Centre, McMaster University, 699 Concession Street, Hamilton, Ontario, L8V 5C2 Canada
    Search for more papers by this author
    • Fax: 905-575-6326

  • Dauna Crooks R.N., B.Sc.N., M.Sc.N., D.N.S.,

    1. Supportive Cancer Care Research Unit, Hamilton Regional Cancer Centre, McMaster University, Hamilton, Ontario, Canada
    Search for more papers by this author
  • Peter M. Ellis M.D., Ph.D.,

    1. Hamilton Regional Cancer Centre, Cancer Care Ontario, Hamilton, Ontario, Canada
    2. Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    Search for more papers by this author
  • Deborah Mings R.N., O.C.N, M.H.Sc.,

    1. Department of Nursing, St. Peters Hospital, Hamilton, Ontario, Canada
    Search for more papers by this author
  • Tim J. Whelan B.M., B.Ch., M.Sc.

    1. Hamilton Regional Cancer Centre, Cancer Care Ontario, Hamilton, Ontario, Canada
    2. Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    3. Supportive Cancer Care Research Unit, Hamilton Regional Cancer Centre, McMaster University, Hamilton, Ontario, Canada
    Search for more papers by this author

  • See related editorial on pages 1397–400, this issue.

Abstract

BACKGROUND

The multiple determinants of a patient's decision to enter into a clinical trial have been explored largely from the perspectives of patients and their physicians. Little research has involved clinical research associates (CRAs) formally, despite their central role in the process of recruitment. The current study was initiated to explore the factors that influence the decision of patients with cancer regarding clinical trial entry, specifically from the perspective of the CRA.

METHODS

Two focus groups of CRAs from the Hamilton Regional Cancer Center were organized. A skilled facilitator guided both groups through exploratory and subsequent confirmatory phases of discussions, which were audiotaped for review and coding using a process of consensus employing intercoder triangulation.

RESULTS

The two groups identified a number of factors that they believed influenced the recruitment process. Numerous physician and patient factors were reaffirmed, such as the impression of the scientific merit of a study or the sense of personal benefit, respectively. More uniquely, CRAs identified information transfer within the informed consent process as a major aspect of their specialized role. It was believed that full disclosure of information, in terms of both the content and the techniques and styles of delivery, was an important predictor of recruitment success. The groups quickly reached consensus on which factors they believed were the most important overall with respect to influencing study recruitment.

CONCLUSIONS

CRAs appear to have a unique role in the process of recruiting patients to active clinical trials. They believe that they have an important influence on recruitment success. Further research to validate this impression is required, because, ultimately, a greater understanding of the relative roles of physician and patient factors and, potentially, CRA factors will be important in the development of ethical and supportive strategies to optimize the recruitment of patients with cancer into randomized clinical trials. Cancer 2002;95:1584–91. © 2002 American Cancer Society.

DOI 10.1002/cncr.10864

Ancillary